Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low Grade Upper Tract Urothelial Carcinoma”

6 trials

Showing 6 of 6 results

Large-scale testing (Phase 3)Looking for participantsNCT06774131
What this trial is testing

Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

Who this might be right for
Upper Urinary Tract Urothelial CarcinomaUrothelial Carcinoma
UroGen Pharma Ltd. 70
Testing effectiveness (Phase 2)Looking for participantsNCT07265947
What this trial is testing

Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

Who this might be right for
Low Grade Upper Tract Urothelial Carcinoma
Tyra Biosciences, Inc 230
Not applicableAvailableNCT05494411
What this trial is testing

Named Patient Program for Mitomycin for Pyelocalyceal Solution

Who this might be right for
Urothelial Cancer of Renal PelvisUrothelial Carcinoma of the Renal Pelvis and UreterUrothelial Carcinoma Ureter+3 more
UroGen Pharma Ltd.
Large-scale testing (Phase 3)Study completedNCT02793128
What this trial is testing

The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study

Who this might be right for
Carcinoma, Transitional CellTransitional Cell Carcinoma of Renal Pelvis
UroGen Pharma Ltd. 71
Testing effectiveness (Phase 2)Looking for participantsNCT06668493
What this trial is testing

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

Who this might be right for
Low-grade Upper Tract Urothelial Carcinoma
Ferring Pharmaceuticals 20
Large-scale testing (Phase 3)WithdrawnNCT04006691
What this trial is testing

Efficacy and Safety of UGN-101 in Recurrent Patients

Who this might be right for
CarcinomaTransitional Cell CarcinomaTransitional Cell Cancer of the Renal Pelvis and Ureter
UroGen Pharma Ltd.

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation